Glitch Advanced Relief Eye Drops Solution/ Drops
NDC Package 0276-0801-15
Package Information
Glitch Advanced Relief Eye Drops (polyethylene glycol 400, tetrahydrozoline hcl) solution/ dropses is instill 1 to 2 drops in the affected eye(s) up to 4 times daily. This formulation utilizes a solution/ drops delivery system. Marketed by Misemer Pharmaceutical, Inc, this product is identified by NDC 0276-0801 and is authorized under FDA application M018.
Identification & Billing
- RxCUI: 996209 - polyethylene glycol 400 1 % / tetrahydrozoline HCl 0.05 % Ophthalmic Solution
- RxCUI: 996209 - polyethylene glycol 400 10 MG/ML / tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution
- RxCUI: 996209 - PEG 400 1 % / tetrahydrozoline hydrochloride 0.05 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0276 - Misemer Pharmaceutical, Inc
- 0276-0801 - Glitch Advanced Relief Eye Drops
- 0276-0801-15 - 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER
- 0276-0801 - Glitch Advanced Relief Eye Drops
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0276-0801-15 identifies a specific commercial package of 1 bottle, dropper in 1 box / 15 ml in 1 bottle, dropper of Glitch Advanced Relief Eye Drops, a human over the counter drug labeled by Misemer Pharmaceutical, Inc. This solution/ drops is formulated for ophthalmic use and contains polyethylene glycol 400; tetrahydrozoline hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Misemer Pharmaceutical, Inc on August 21, 2023. The current certification is valid through December 31, 2026.
How is this Misemer Pharmaceutical, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00276080115. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.